Feb 17 (Reuters) - QBE Insurance (QBE) :
- EXPECT GROSS WRITTEN PREMIUM GROWTH TO BE IN MID-TO-HIGH SINGLE DIGITS IN 2023
- FY ADJUSTED NET CASH PROFIT AFTER TAX $847 MILLION VERSUS $805 MILLION
- EXPECT RECENT MOMENTUM WILL CONTINUE INTO 2023
- DECLARES FINAL DIVIDEND OF 30 AU CENTS PER SHARE
- MARKET CONDITIONS EXPECTED TO REMAIN SUPPORTIVE IN 2023
- FY GROSS WRITTEN PREMIUMS $20,001 MILLION VERSUS $18,457 MILLION
- FY COMBINED OPERATING RATIO (EX RISK-FREE RATE) OF 94.2% VERSUS 93.7% IN PRIOR YEAR
- EXPECT HIGHER INFLATION WILL REMAIN PERSISTENT IN YEAR AHEAD
- OPTIMISTIC ABOUT THE YEAR AHEAD
- CONTINUE TO EXPECT A GROUP EXPENSE RATIO OF AROUND 13% IN 2023
- EXPECT CLIMATE CHANGE WILL INCREASINGLY IMPACT FREQUENCY AND SEVERITY OF WEATHER-RELATED NATURAL CATASTROPHES OVER LONG TERM
- Forums
- ASX - By Stock
- QBE
- News: QBE QBE Insurance Posts FY Adjusted Net Cash Profit After Tax $847 Million
QBE
qbe insurance group limited
Add to My Watchlist
0.89%
!
$21.62

News: QBE QBE Insurance Posts FY Adjusted Net Cash Profit After Tax $847 Million
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$21.62 |
Change
0.190(0.89%) |
Mkt cap ! $32.67B |
Open | High | Low | Value | Volume |
$21.85 | $21.85 | $21.49 | $49.52M | 2.284M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 1592 | $21.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.62 | 3335 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 1845 | 21.610 |
20 | 5303 | 21.600 |
25 | 3682 | 21.590 |
15 | 3293 | 21.580 |
10 | 3625 | 21.570 |
Price($) | Vol. | No. |
---|---|---|
21.620 | 2247 | 27 |
21.630 | 2509 | 15 |
21.640 | 3307 | 17 |
21.650 | 2105 | 9 |
21.660 | 2600 | 12 |
Last trade - 13.15pm 22/08/2025 (20 minute delay) ? |
Featured News
QBE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online